Biomedical Engineering and Bioengineering Commons^™

Thrombin-Inhibiting Perfluorocarbon Nanoparticles: A New Class Of Therapeutic For Acute Thrombosis Treatment And Diagnosis, Jacob Wheatley Myerson

All Theses and Dissertations (ETDs)

Optimization of the mediation of acute thrombi remains a significant research challenge in the treatment of emergency conditions including heart attack and ischemic stroke. We have demonstrated that a nanoparticle carrying potent direct thrombin inhibitors can advance the treatment of acute thrombosis arising from various cardiovascular pathologies. The thrombin-inhibiting nanoparticles presented herein are designed to focus the antithrombotic impact of direct thrombin inhibitors at the site of thrombus formation and to provide imaging contrast to highlight the formation or the abatement and eventual disintegration of the thrombus.

Perfluorocarbon nanoparticles were functionalized by covalent addition of PPACK or bivalirudin to carboxy-PEG …